BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30904026)

  • 1. Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution.
    Sudo M; Furuya S; Shimizu H; Nakata Y; Iino H; Shiraishi K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
    World J Surg Oncol; 2019 Mar; 17(1):56. PubMed ID: 30904026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
    Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
    Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
    Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
    Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors associated with primary cancer in curatively resected stage IV colorectal cancer.
    Huh JW; Lee WY; Park YA; Cho YB; Yun SH; Kim HC; Chun HK
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):435-41. PubMed ID: 24414039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
    Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
    Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of stage IV colorectal cancer after R0 resection: a multi-institutional retrospective analysis.
    Sato H; Maeda K; Morise Z; Takahashi H; Sugihara K;
    Int J Clin Oncol; 2017 Apr; 22(2):297-306. PubMed ID: 27714536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of primary tumor resection in stage IV colorectal cancer with unresectable metastasis: a multicenter retrospective study using a propensity score analysis.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2015 Jun; 30(6):807-12. PubMed ID: 25922146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
    Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
    Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
    Anannamcharoen S; Boonya-Ussadol C
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indicators for surgical resection and intraoperative radiation therapy for pelvic recurrence of colorectal cancer.
    Hashiguchi Y; Sekine T; Kato S; Sakamoto H; Nishimura Y; Kazumoto T; Sakura M; Tanaka Y
    Dis Colon Rectum; 2003 Jan; 46(1):31-9. PubMed ID: 12544519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting survival in surgical palliative resection of stage IV colorectal cancer.
    Scabini S; Rimini E; Romairone E; Scordamaglia R; Pertile D; Ferrando V
    Minerva Chir; 2009 Jun; 64(3):303-6. PubMed ID: 19536056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.
    Li Q; Liang L; Jia H; Li X; Xu Y; Zhu J; Cai S
    Oncotarget; 2016 Nov; 7(44):72290-72299. PubMed ID: 27474167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
    Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
    World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Resection of Colorectal Cancer With Distant Metastases to Other than Liver or Lung.
    Naito A; Kagawa Y; Kawai K; Takeno A; Takeda Y; Ohtsuka M; Suzuki Y; Imasato M; Fujie Y; Nakaba H; Akamatsu H; Murata K
    In Vivo; 2019; 33(5):1605-1608. PubMed ID: 31471411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.